We used a novel Simoa assay to quantify CSF levels of PSD-95, an important component of post-synaptic densities, in subjects with AD and related these levels to two more established synaptic markers, SNAP-25 and Ng. This evidence concerns the gene NRGN and Alzheimer disease.